These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22593595)

  • 1. Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections.
    Holmes NE; Johnson PD; Howden BP
    J Clin Microbiol; 2012 Aug; 50(8):2548-52. PubMed ID: 22593595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
    Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
    Gomes DM; Ward KE; LaPlante KL
    Pharmacotherapy; 2015 Apr; 35(4):424-32. PubMed ID: 25884530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.
    Howden BP; Davies JK; Johnson PD; Stinear TP; Grayson ML
    Clin Microbiol Rev; 2010 Jan; 23(1):99-139. PubMed ID: 20065327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloxacillin-susceptible Staphylococcus aureus with high MIC to glycopeptides. Ever we use cloxacillin?].
    Morales-Cartagena A; Lalueza A; San Juan R; Aguado JM
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():25-9. PubMed ID: 26365730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancomycin-resistant Staphylococcus aureus].
    Rodríguez CA; Vesga O
    Biomedica; 2005 Dec; 25(4):575-87. PubMed ID: 16433184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.
    Moise PA; North D; Steenbergen JN; Sakoulas G
    Lancet Infect Dis; 2009 Oct; 9(10):617-24. PubMed ID: 19778764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient--importance of low-level resistance to vancomycin.
    Haraga I; Nomura S; Fukamachi S; Ohjimi H; Hanaki H; Hiramatsu K; Nagayama A
    Int J Infect Dis; 2002 Dec; 6(4):302-8. PubMed ID: 12718825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit.
    Chua T; Moore CL; Perri MB; Donabedian SM; Masch W; Vager D; Davis SL; Lulek K; Zimnicki B; Zervos MJ
    J Clin Microbiol; 2008 Jul; 46(7):2345-52. PubMed ID: 18508934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital.
    Sancak B; Ercis S; Menemenlioglu D; Colakoglu S; Hasçelik G
    J Antimicrob Chemother; 2005 Sep; 56(3):519-23. PubMed ID: 16046461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.